Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MNPR-101-PCTA-177Lu
BIOLOGICAL
2 trials
Sponsors
Monopar Therapeutics
Conditions
Bladder Cancer
Cancer
Colorectal Cancer
Gastric Cancer
Lung Cancer
Oncology
Ovarian Cancer
Pancreatic Cancer
+7 more
Phase 1
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Active, not recruiting
NCT06617169
Monopar Therapeutics
Bladder Cancer, Colorectal Cancer, Gastric Cancer +6
Start: 2024-10-08
End: 2027-02-01
Target: 12
Updated: 2026-09-03
Unknown Phase
MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
NCT06980519
Monopar Therapeutics
Cancer, Oncology, Solid Tumor +3
Updated: 2026-09-04